Advertisement
Screener

ADAGIO MEDICAL HOLDINGS, INC. (ADGM) Investing Cash Flow

2.1 / 5 stars · 3/7 Roast Me

ADAGIO MEDICAL HOLDINGS, INC. Investing Cash Flow

ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Investing Cash Flow of -$8.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-11

  • ADAGIO MEDICAL HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$6.00K.
  • ADAGIO MEDICAL HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$2.00K.
  • ADAGIO MEDICAL HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $491.00K.
  • ADAGIO MEDICAL HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$520.00K.
  • ADAGIO MEDICAL HOLDINGS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$374.00K.
  • ADAGIO MEDICAL HOLDINGS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$340.00K.
Period endNet Cash Provided by (Used in) Investing Activities 2 monthNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 5 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 7 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2026-06-30-$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
-$8.00K
10-Q · filed 2026-08-11
$483.00K
derived: sum of 3 quarters · filed 2026-08-11
-$37.00K
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31-$2.00K
10-Q · filed 2026-05-12
$489.00K
derived: sum of 2 quarters · filed 2026-05-12
-$31.00K
derived: sum of 3 quarters · filed 2026-05-12
-$41.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31$491.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$29.00K
derived: sum of 2 quarters · filed 2026-03-27
-$39.00K
derived: sum of 3 quarters · filed 2026-08-11
-$374.00K
10-K · filed 2026-03-27
2025-09-30-$520.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$530.00K
derived: sum of 2 quarters · filed 2026-08-11
-$865.00K
10-Q · filed 2025-11-12
2025-06-30-$10.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
-$345.00K
10-Q · filed 2026-08-11
2025-03-31-$335.00K
10-Q · filed 2026-05-12
2024-12-31-$1.28M
10-K · filed 2026-03-27
2024-09-30-$578.00K
10-Q · filed 2025-11-12
2024-07-30-$368.00K
10-K · filed 2026-03-27
2024-06-30-$175.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$337.00K
10-Q · filed 2025-08-14
-$357.00K
derived: sum of 3 quarters · filed 2025-08-14
2024-03-31-$162.00K
10-Q · filed 2025-05-15
-$182.00K
derived: sum of 2 quarters · filed 2025-05-15
2023-12-31-$20.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
-$340.00K
10-K · filed 2025-03-27
2023-09-30-$320.00K
10-Q · filed 2024-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Autonomix Medical, Inc. (AMIX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23